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Dear Editor,
I read with some interest the article by Berilgen
et al.1 Although I have great respect for the authors
and their respective and collective insight, there
are a few issues concerning ghrelin level that this
article did not address.
First, they reported that total (acyl-modified plus
des-acyl ghrelins) was very low in patients with and
without epilepsy, whereas the normal total ghrelin
concentration of blood samples in human is 100—
150 fmol/ml.2 Possible reason for this observation is
that ghrelin is easily digested by many proteases in
cells. Thus, to measure ghrelin concentration, it is
necessary to use aprotinin when collecting blood
samples unless analyzed immediately. It should be
also treated with 1/10 volume of 1N HCl before
keeping samples in the freezer.2 If they did not
inhibit protease digestion of the ghrelin peptide,
which should theoretically be the case, then a low
level of the ghrelin was detected.
Second, the observed results are controversial3
and somewhat perplexed, since antiepileptic drugs
(AEDs) that promote weight gain include valproate,
carbamazepineandgabapentin.4Weknewthat blood
ghrelin levels were lower in obese subjects than the
age matched lean controls.2 If the treatment caused
weight gain, it was therefore hard to explain why
ghrelin level increased instead of decrement in the
epileptic patients treated with antiepileptic drugs.
They also reported ghrelin was still within normal
physiological condition. If so, how, then to say ghrelin
level linked with epilepsy. There may be other
mechanisms where we have not known as yet.1059-1311/$ — see front matter # 2006 British Epilepsy Association
doi:10.1016/j.seizure.2006.07.001Finally, in such a comparative study the measur-
ing total ghrelin cannot go to right address. Since,
octanoylated ghrelin is the bioactive peptide, which
is responsible for the physiological response.2 So,
they are supposed to use an assay able to discrimi-
nate these two forms. Therefore, I can say that the
study is purely descriptive and no biochemical
mechanism was explored either in the regulation
of ghrelin in epilepsy or for the functional conse-
quences of the putative changes described.References
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